P1.15-04 Dynamic Profiling of Blood Immunophenotypes and Radiomic Features to Predict Immunotherapy Response in Advanced Non-small Cell Lung Cancer
JOURNAL OF THORACIC ONCOLOGY(2022)
Abstract
Up to date, no predictive biomarkers can robustly identify patients with non-small cell lung cancer (NSCLC) who will benefit from immune checkpoint inhibitors (ICIs). Thus, we sought to non-invasively decode tumor-immune interactions implicated in ICI response by exploring the dynamic of blood immune-inflammatory markers and radiomic features in a cohort of advanced NSCLC treated with ICIs.
MoreTranslated text
Key words
Non-small cell lung cancer,Immunotherapy,Immunophenotypes
AI Read Science
Must-Reading Tree
Example
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined